Stevanato Group S.p.A. (STVN) IPO Opens 21% Lower

Today's IPO for Stevanato Group S.p.A. (NYSE: STVN) opened for trading at $16.65 after pricing 32,000,000 of its ordinary shares at a price of $21 per share.

Morgan Stanley, BofA Securities and Jefferies are acting as lead book-running managers for the offering. Citigroup, UBS Investment Bank, KeyBanc Capital Markets, Wells Fargo Securities and William Blair are acting as book runners for the offering.

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

You May Also Be Interested In

• VICI Properties closes $1.75B senior unsecured notes offering
• AbCellera prices $200M public offering of shares and warrants
• Silence Therapeutics closes $201M public offering of ADSs